Medstar Franklin Square Medical Center
Clinical research site in Baltimore, Maryland · 9000 FRANKLIN SQUARE DR, BALTIMORE, MD 21237-3901 · (443) 777-7000 · Website
Part of MedStar Franklin Square Medical Center
3.8on Google· View on Google Maps
As of September 2026, 14 paid clinical trials are recruiting at Medstar Franklin Square Medical Center in Baltimore, Maryland. Active studies at this site cover conditions such as Colorectal Neoplasms, Solid Tumors and Hematologic Malignancies. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Medstar Franklin Square Medical Center (14)
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries
Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Get new-trial alerts for Medstar Franklin Square Medical Center
We'll email you whenever a new clinical trial starts recruiting at this research site in Baltimore, MD. Unsubscribe anytime.
More research sites in Baltimore
- Johns Hopkins University (190 trials)
- Johns Hopkins Hospital (125 trials)
- Johns Hopkins University/Sidney Kimmel Cancer Center (63 trials)
- University of Maryland (57 trials)
- Sinai Hospital of Baltimore (48 trials)
- University of Maryland Medical Center (46 trials)
- University of Maryland/Greenebaum Cancer Center (42 trials)
- Johns Hopkins University School of Medicine (40 trials)
- Johns Hopkins (37 trials)
- Kennedy Krieger Institute (30 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Baltimore, MD · Maryland clinical trials